Medtronic plc is sponsoring a randomized trial to evaluate the ability of a new algorithm for the Reveal LINQ insertable cardiac monitor to identify patients at high risk of worsening heart failure.
Reveal LINQ is a monitor about one-third the size of a AAA battery that is inserted just beneath the skin through a small incision in the upper left side of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?